Athyros V G, Didangelos T P, Karamitsos D T, Papageorgiou A A, Boudoulas H, Kontopoulos A G
Division of Cardiology, Aristotelian University, Hippokration Hospital, Thessaloniki, Greece.
Acta Cardiol. 1998;53(4):201-9.
Autonomic nervous system function in patients with diabetes mellitus (DM), especially those with diabetic autonomic neuropathy (DAN), displays an abnormal circadian pattern compared to normal subjects; this probably plays an important role in the onset of acute cardiovascular syndromes, which display a similar pattern of occurrence with a blunted late morning peak, and an increase of episodes during the night, in comparison to non-diabetic subjects. This study was undertaken to investigate the effect of an angiotensin-converting enzyme inhibitor, quinapril, on the circadian pattern of heart rate variability (HRV), a reliable index of sympathovagal interactions, in patients with definite DAN.
METHODS & RESULTS: Normalised HRV frequency domain indices [high frequency power (HFP), reflecting vagal tone, low frequency power (LFP), reflecting both vagal and sympathetic (predominantly) modulation, and their ratio (LFP/HFP), indicative of sympathovagal balance] were assessed in 60 patients with DAN at baseline and one year after therapy with quinapril (n = 30), or placebo (n = 30) on a 24-hour 2-channel electrocardiogram with a solid state Holter monitor. Normal subjects (n = 30) and patients with DM without DAN (n = 30), were used as controls. The baseline circadian variation of fractional normalised power in DAN patients was abolished, with pronounced dominance of LFP over HFP during the whole 24-hour period. After one year of treatment, quinapril increased HFP, decreased LFP and improved their ratio, in the morning (07.00 a.m. to 15.00 p.m.) and night (23.00 p.m. to 07.00 a.m.) time intervals, with maximal effect in the night time interval (HFP = 20%, LFP = -8%, LFP/HFP = -31%; for all comparisons p < 0.05 vs baseline values and p < 0.001 vs one year of placebo).
Quinapril increased HFP and decreased LFP as well as their ratio, all indicative of sympathetic predominance reduction, in patients with DAN at time intervals these indices were most adversely affected (morning and night). Since autonomic function is an important contributor in the pathogenesis of acute coronary events, malignant arrhythmias and sudden cardiac death, improvement of indices related to autonomic function in DAN patients in these time intervals may prove beneficial in clinical practice.
与正常受试者相比,糖尿病(DM)患者,尤其是患有糖尿病性自主神经病变(DAN)的患者,自主神经系统功能呈现异常的昼夜节律模式;这可能在急性心血管综合征的发病中起重要作用,与非糖尿病受试者相比,急性心血管综合征的发生模式类似,即清晨高峰变钝,夜间发作增加。本研究旨在调查血管紧张素转换酶抑制剂喹那普利对确诊为DAN的患者心率变异性(HRV)昼夜节律模式的影响,HRV是交感神经 - 迷走神经相互作用的可靠指标。
在60例DAN患者中,使用固态动态心电图监测仪,在基线时以及使用喹那普利(n = 30)或安慰剂(n = 30)治疗一年后,评估标准化的HRV频域指标[高频功率(HFP),反映迷走神经张力;低频功率(LFP),反映迷走神经和交感神经(主要是)调制;以及它们的比值(LFP/HFP),指示交感神经 - 迷走神经平衡]。正常受试者(n = 30)和无DAN的DM患者(n = 30)作为对照。DAN患者中分数标准化功率的基线昼夜变化消失,在整个24小时期间LFP明显高于HFP。治疗一年后,喹那普利在上午(上午07:00至下午15:00)和夜间(晚上23:00至上午07:00)时间段增加了HFP,降低了LFP并改善了它们的比值,在夜间时间段效果最大(HFP = 20%,LFP = -8%,LFP/HFP = -31%;所有比较,与基线值相比p < 0.05,与安慰剂治疗一年相比p < 0.001)。
喹那普利在这些指标受影响最不利的时间段(上午和夜间)增加了DAN患者的HFP,降低了LFP及其比值,所有这些都表明交感神经优势降低。由于自主神经功能是急性冠状动脉事件、恶性心律失常和心源性猝死发病机制中的重要因素,在这些时间段改善DAN患者与自主神经功能相关指标在临床实践中可能被证明是有益的。